top of page

Developing innovative therapies that bring new hope to patients with dilated cardiomyopathy (DCM) — that is the mission of CardioGenix.

CardioGenix-logo

Shaping the Future of

Cardiomyopathy

Your contributions accelerate Dilated Cardiomyopathy (DCM) drug development. Donors receive regular research updates and exclusive progress reports.

Supporter

10 USD+

✉️ Thank You Email

📋 Donor List inclusion    (Optional)

Research Supporter

50 USD+

🗞️ + Priority Research

   Newsletter

Research Partner

Recommended

100 USD+

✨ + Exclusive Online Briefing    Invitations

500 USD+

Core Supporter

🤝 + Zoom Meet-and-Greet

          with CEO

1,000 USD+

Special Partner

🏆+ Acknowledgement in           Research Report

bottom of page